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A B S T R A C T
Background: Genetic risk and environmental adversity—both important risk factors for major depression
(MD)—are thought to differentially impact on depressive symptom types and associations. Does heterogeneity in
these risk factors result in different depressive symptom networks in patients with MD?
Methods: A clinical sample of 5784 Han Chinese women with recurrent MD were interviewed about their de-
pressive symptoms during their lifetime worst episode of MD. The cases were classified into subgroups based on
their genetic risk for MD (family history, polygenic risk score, early age at onset) and severe adversity (childhood
sexual abuse, stressful life events). Differences in MD symptom network structure were statistically examined for
these subgroups using permutation-based network comparison tests.
Results: Although significant differences in symptom endorsement rates were seen in 18.8% of group compar-
isons, associations between depressive symptoms were similar across the different subgroups of genetic and
environmental risk. Network comparison tests showed no significant differences in network strength, structure,
or specific edges (P-value>0.05) and correlations between edges were strong (0.60–0.71).
Limitations: This study analyzed depressive symptoms retrospectively reported by severely depressed women
using novel statistical methods. Future studies are warranted to investigate whether similar findings hold in
prospective longitudinal data, less severely depressed patients, and men.
Conclusions: Similar depressive symptom networks for MD patients with a higher or lower genetic or environ-
mental risk suggest that differences in these etiological influences may produce similar symptom networks
downstream for severely depressed women.
1. Introduction
Major depression (MD) is a heterogeneous disorder in terms of
presentation, course of illness and treatment response (Cuijpers et al.,
2012; Eaton et al., 2008; Hardeveld et al., 2013; Holma et al., 2008;
Oquendo et al., 2004; Simon and Perlis, 2010). This heterogeneity may
also be reflected in its etiology. That is, it is likely that many different
pathways can lead to the syndrome of MD as opposed to MD being the
result of one common complex pathway (Kendler, 2013; Krishnan and
Nestler, 2008; Milaneschi et al., 2016; Wichers, 2014).
Two of the most prominent risk factors for MD are genetic risk
(Kendler et al., 2006; Sullivan et al., 2000) and environmental adversity
(Chen et al., 2014; Kendler et al., 1999; Tao et al., 2011). These broad
distinct risk factors might be associated with differential pathways to
MD, including specific (neuro)biological differences (Krishnan and
Nestler, 2008; Pittenger and Duman, 2008). However, risk factors could
also impact on aspects of the disorder further downstream, such as how
symptoms interact within a complex network.
When viewing symptoms within a network theory perspective, MD
develops and persists through direct interactions among its defining
symptoms, such as depressed mood, insomnia, fatigue, and concentra-
tion difficulties (Borsboom, 2017; Cramer et al., 2010; Fried et al.,
2017). Different risk factors related to genes or environmental adversity
are hypothesized to influence the strength of these connections between
symptoms, which may produce individual differences in liability to
develop the disorder (Borsboom, 2017; Cramer et al., 2011; Wichers,
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2014). There is some evidence that network connectivity may differ
across persisting and remitting cases of MD (Van Borkulo et al., 2015).
It is unclear, however, whether heterogeneity in these risk factors leads
to clinical variation in the presentation of MD once a syndrome has
occurred. In particular, it is unknown whether differences in symptom
network structure can be detected across subgroups that differ on risk
factors.
Finding potential differences in group-level symptom networks
would be important to improve our understanding of MD’s hetero-
geneity by clarifying potential self-sustaining mechanisms and tailoring
treatments for specific subtypes of MD (Borsboom, 2017; Fried et al.,
2017). For example, if insomnia would trigger many other symptoms
specifically in patients with adversity-related depression, treatments
targeting sleep problems would be expected to be more effective in this
subgroup than in patients unexposed to adversity (Fried et al., 2017).
On the other hand, if depressive symptom networks are robust across
different levels of genetic and environmental risk, this would suggest
that these distinct etiological pathways upstream might eventuate in a
final common pathway downstream.
This study thus aims to examine differences in depressive symptom
networks during episodes of MD across different levels of genetic risk
and environmental adversity in a large sample of Han Chinese women




Data are from the China, Oxford, and VCU Experimental Research
on Genetic Epidemiology (CONVERGE) project, a study of Han Chinese
women with recurrent major depression aimed at identifying genetic
risk factors for MD in a rigorously ascertained cohort (CONVERGE
Consortium, 2015). Major depression cases (n = 5864) were recruited
from 58 provincial mental health centers and psychiatric departments
of general medical hospitals in 45 cities and 23 provinces of China.
Cases were between 30 and 60 years of age and had two or more epi-
sodes of MD meeting DSM-IV criteria with the first episode between
ages 14 and 50, had not abused drugs or alcohol before their first de-
pressive episode, and reported no history of schizophrenia or mania.
A diagnosis of MD was based on a face-to-face interview with a
trained clinician using the Composite International Diagnostic
Interview (CIDI; World Health Organization lifetime version 2.1;
Chinese version), which classifies MD according to DSM-IV criteria
(American Psychiatric Association, 1994). A previous study using latent
variable measurement invariance testing showed that the 9 aggregated
and 14 disaggregated DSM-criteria for MD perform similarly in the
CONVERGE sample when compared to other matched samples from the
United States and Europe (Kendler et al., 2015). The study protocol was
approved by the Ethical Review Board of Oxford University and the
ethics committees of all participating hospitals. All participants pro-
vided written informed consent. A more detailed description of the




Trained postgraduate medical students, junior psychiatrists or se-
nior nurses interviewed the ascertained MD patients on a broad set of
depressive and anxiety symptoms during their most severe lifetime
episode of MD using a structured computerized questionnaire.
Assessment of depressive symptoms was based on the CIDI, supple-
mented by questions about symptoms of melancholia, anxiety, loss of
self-confidence and self-esteem, hopelessness and helplessness, crying
and decreased libido. For this study, the core MD criteria of depressed
mood and interest loss were dropped from the analyses due to the ex-
tremely high positive endorsement rates (99.6% and 98.9%, respec-
tively). In total, we analyzed 24 dichotomously coded symptoms in-
cluding a) the 12 disaggregated DSM-criteria for major depression and
b) 12 additional symptoms commonly experienced by depressed pa-
tients derived from a range of sources including Beck’s work (Beck
et al., 1980) and the DSM-IV criteria for melancholia (American
Psychiatric Association, 1994) in order to investigate the network
structure of a broad set of DSM and non-DSM symptoms (Fried, 2017;
Fried et al., 2016a; Guloksuz et al., 2017). Cases with missing data on
one or more of the 24 symptoms were excluded for all statistical ana-
lyses. We excluded 70 cases with missing data on any of the 24
symptoms, resulting in a sample of 5784 cases included in the statistical
analyses.
2.2.2. Genetic risk measures
To test for network differences related to genetic effects, we com-
pared depressive symptom networks for patients with higher vs. lower
genetic risk of MD. Three indexes of genetic risk were used: a positive
family history of MD, a high polygenic risk score (PRS), and an earlier
age at onset.
First, family history of lifetime MD was coded positive if the subject
reported a lifetime episode of MD in at least one of her biological
parents and siblings according to the Research Diagnostic Criteria
Family History (Endicott et al., 1978). Family history was coded ne-
gative if the subject reported no family members with MD, and had
reported on the MD status of at least two family members (otherwise
family history was set to missing).
Second, a binary variable indicating high PRS for MD was created
based on a PRS within the highest quartile of all cases (Peterson et al.,
2016). Details on DNA sequencing and imputation have been pre-
viously reported (Cai et al., 2017; CONVERGE Consortium, 2015;
Peterson et al., 2016). In brief, CONVERGE obtained sequence data of
11,670 samples and imputed genotypes using methods previously de-
scribed in Cai et al. (2017). After quality control, 5303 cases of MD and
5337 controls remained included for genome wide association analysis
(CONVERGE Consortium, 2015). In this sample, we derived PRS for MD
by randomly dividing all cases and controls into independent training
and testing sets (50–50% split). We estimated SNP effects for risk of MD
by the best linear unbiased prediction (BLUP) method implemented in
GCTA (Yang et al., 2011) using the training set and tested these ag-
gregate genome-wide scores in the testing set. PRS scores were con-
structed using the profile option in PLINK (Chang et al., 2015; Purcell
et al., 2007) and SNPs were weighted by their BLUP parameter esti-
mates. To reduce the effect of population stratification (Patterson et al.,
2006; Price et al., 2006), the PRS was adjusted for the first two prin-
cipal components reflecting ancestry, which distinguished north-south
regional differences. This PRS was significantly associated with case-
control status (P<4.6×10−5), accounting for 1.1% of the variability
in MD risk (Peterson et al., 2016).
Third, early age of onset was defined as cases who reported a first
episode of MD before the age of 28 (i.e. lowest quartile); normal or
older age at onset was defined as a first episode at age 28 years or older.
A younger age at first onset is a modest index of familial liability,
particularly before age 25, up to age 35 (Docherty et al., 2017; Kendler
et al., 2005). Recent research found differences in genetic architecture
for age at onset of MD, with cases with early age at onset showing
greater genetic similarities with schizophrenia and bipolar (Power
et al., 2017; Verduijn et al., 2017), although a recent study in CON-
VERGE did not find an association between age at onset and common
variant PRS for MD (Docherty et al., 2017). To keep the sample size of
the early age at onset subsample sufficiently large, we selected cases
within the lowest quartile of age at onset, instead of studying a sub-
sample with a lower age at onset.
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2.2.3. Adversity measure
To test for network differences related to severe environmental
adversity, we compared depressive symptom networks for patients with
higher vs. lower environmental risk of MD. A binary index of adversity
was created from self-reported stressful life events (SLE) and childhood
sexual abuse (CSA) in order to identify individuals exposed to severe
environmental adversities. The SLE questionnaire was adapted from the
Virginia Adult Twin Study of Psychiatric and Substance Use Disorders
(Kendler and Prescott, 2006) and assessed 16 traumatic lifetime events
and the age of their occurrence (Tao et al., 2011) (Additional Table 1).
Because there is evidence that sensitive subjects like CSA are more
accurately reported on using more confidential methods of assessment
(Laumann et al., 1994), participants were asked to complete a paper
questionnaire about CSA. The CSA questionnaire was a shortened ver-
sion of a scale developed by Martin et al. (1993) and queried whether,
before the subject was 16, had any adult, or any other older person,
initiated any unwanted sexual advances like kissing or hugging in a
sexual way, touching or fondling private parts, showing their sex or-
gans, making them touch the person in a sexual way, or attempting or
having sexual intercourse (Chen et al., 2014). The possible responses
were “never,” “once,” and “more than once.” While it is known that the
patterns of association with MD differ between some forms of en-
vironmental stressors (Kessler, 1997), this heterogeneity is expected to
be relatively small and so for these analyses we grouped them together
to maximize statistical power and reduce multiple testing. Subjects
were considered an “adversity case” if they i) had non-missing data on
SLE and CSA scales and ii) endorsed any CSA and/or had high ag-
gregate SLE scores (+3 SD). Since SLE vary in severity, the SLE score
was constructed by weighting each item by their effect size on MD and
summed across each of the 16 items. SLE for MD cases were only in-
cluded if they preceded MD onset. Using this adversity exposure status,
we grouped the sample into those “exposed” and those “unexposed”.
2.3. Statistical methods
2.3.1. Assessing differences in symptom endorsements
Four pairwise comparisons were carried out assessing both
symptom endorsement and network structure for all the defined sub-
samples: 1) family history positive vs. negative; 2) high vs. low PRS; 3)
earlier vs. later age at onset; 4) adversity exposed vs. unexposed.
Differences in endorsement rates for all 24 symptoms were assessed by
chi-squared tests using Bonferroni-corrected alphas (α = 0.0005).
Similarities in endorsement rates were examined by Spearman rank-
order correlations.
2.3.2. Network estimation
We estimated the appropriate network model for dichotomous data
–the Ising Model– via the IsingFit package (gamma = 0.25; Van
Borkulo et al., 2014). In these networks, “edges” (i.e. relationships
among symptoms) are estimated using regularized logistic regressions
(Van Borkulo et al., 2014). Each symptom is regressed on all others, and
an L1-penalty is imposed on the regression coefficients for an optimal
balance between parsimony and goodness of fit. The strength of the
edge is the average of the regression coefficients from the two reg-
ularized logistic regressions of symptom 1 on symptom 2 (adjusted for
all other symptoms) and symptom 2 on symptom 1 (adjusted for all
other symptoms) (note that due to applying the AND-rule, both re-
gression coefficients need to be non-zero). This estimation method has a
high specificity (i.e. connections that are included in the estimated
network almost certainly reflect nonzero parameters at population
level) and acceptable sensitivity (Van Borkulo et al., 2014). For an
extensive explanation of the method we refer to Van Borkulo et al.
(2014). The accuracy and stability of the network estimation was fur-
ther examined using non-parametric bootstrap methods (R-package
bootnet, 1000 bootstrapped samples) (Epskamp et al., 2017).
2.3.3. Network comparisons
First, the recently developed Network Comparison Test (NCT) was
used to statistically compare two networks on three aspects: (1) net-
work structure, (i.e., are the distributions of edge weights similar), (2)
global strength (i.e., are the sums of all absolute edge weights similar),
and (3) individual edge strength (i.e., are individual edge weights si-
milar) (Van Borkulo et al., 2017). NCT uses two-tailed permutation tests
in which the original group members are repeatedly randomly reas-
signed to new subsamples that maintain the original sample sizes (1000
times), after which their network structures were compared on the
three aspects described above. The resulting distribution under the null
hypothesis (under the assumption that groups are equal) can be used to
test whether the observed differences between the original groups are
statistically significant (α = 0.05). The test on individual edge weights
uses a Holm-Bonferroni correction for multiple testing. See Van Borkulo
et al. (2017) for a more detailed description of NCT.
Second, the degree of similarity among individual edge weights
across networks were assessed with Spearman rank-order correlations.
Third, to get an impression of the independent tendency of symp-
toms to be non-zero, we compared the intercepts for each symptom
(also referred to as “thresholds”) across the subsamples. The thresholds
represent the intercept for each symptom in the regularized logistic
regression analyses used to estimate the networks. All analyses were
performed in R (R Core Team, 2017). We used R-package qgraph to
visualize networks (Epskamp et al., 2012). For further details, we refer
to the R-script included in the Additional material.
3. Results
3.1. Sample
The 5784 ascertained women with recurrent MD and complete data
on all 24 depressive symptoms had a mean age at interview of 44.4
years (SD 8.9) and reported on average 5.2 previous depressive epi-
sodes (SD 8.9). Their mean age at onset was 34.8 years (SD 10.0) and
their mean age at the worst episode was 40.3 years (SD 9.7), resulting
in a mean recall period regarding their symptoms during the worst
depressive episode of 4.0 years (SD 5.7). Of these cases, 27.7% reported
a positive family history, 75.6% reported at least one lifetime SLE, and
10.3% experienced any CSA (8.7% nongenital, 6.5% genital, 2.8% in-
tercourse). In total, 34.0% classified as adversity exposed (i.e. reported
CSA and/or high aggregate SLE scores (+3 SD)). Additional Table 1
shows endorsement rates of each SLE among MD-cases.
The three indexes of genetic risk and the index of environmental risk
were at most weakly positively correlated. Family history, early age at
onset, and adversity were weakly positively correlated, whereas a high
PRS was not correlated with any of the other indicators of genetic risk
or adversity (Table 1).
3.2. Symptom endorsement rates
As reported elsewhere (Kendler et al., 2015; Li et al., 2014), en-
dorsement rates in the MD case sample were high (> 90%) for con-
centration difficulties, fatigue, distinct quality of depressed mood,
Table 1
Correlations between measures of genetic and environmental risk.
FH positive AAO<28 Adversity
AAO<28 0.14 (0.09–0.19)
Adversity 0.20 (0.15–0.25) 0.14 (0.10–0.18)
PRS high 0.03 (−0.02–0.08) 0.02 (−0.03–0.07) −0.03 (−0.08–0.02)
AAO, age at onset; FH, family history; PRS, polygenic risk score.
Numbers represent bivariate tetrachoric correlations and 95% confidence intervals in
parentheses.
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insomnia, and feelings of guilt or worthlessness. In total, 12 out of 24
symptoms were endorsed by>80% of the sample. Less frequently ex-
perienced symptoms included those described in the DSM-specifier for
atypical depression: hypersomnia (13.1%), increased appetite (9.5%),
and weight gain (6.7%) (Table 2, Fig. 1).
Symptom endorsement rates were very similar for the different
subsamples: 78 out of 96 chi-squared tests (81.3%) comparing symptom
endorsement rates for each of the four subsample comparisons were not
Table 2
Symptom endorsement rates (%) by comparison groups.
All FH neg. FH pos. χ2 P PRS low PRS high χ2 P AAO>= 28 AAO<28 χ2 P No adv. Adv. χ2 P
N 5784 3907 1494 3909 1301 4149 1477 3511 1812
Appetite loss 83.4 83.5 83.7 0.1 0.778 82.8 84.9 3.1 0.080 85.0 79.7 21.2 0.000 84.5 81.1 9.8 0.002
Weight loss 58.8 57.8 61.6 6.4 0.011 58.9 58.3 0.1 0.745 60.5 54.4 15.5 0.000 58.6 58.8 0.0 0.934
Appetite gain 9.5 9.1 10.2 1.2 0.266 10.2 7.1 10.0 0.002 8.4 12.3 18.7 0.000 7.8 13.0 36.3 0.000
Weight gain 6.7 6.2 7.3 1.9 0.163 6.9 5.5 2.4 0.124 6.1 8.5 9.5 0.002 5.5 9.1 24.7 0.000
Insomnia 92.3 92.5 92.2 0.0 0.877 92.5 91.6 0.5 0.469 93.4 90.0 17.5 0.000 93.3 91.1 8.8 0.003
Hypersomnia 13.1 11.7 16.4 20.8 0.000 12.7 13.5 0.4 0.541 11.6 17.3 30.0 0.000 11.7 16.2 19.8 0.000
Psychomotor
retardation
76.0 76.0 77.2 0.9 0.346 75.3 77.8 3.1 0.077 75.9 76.5 0.2 0.642 76.2 77.0 0.2 0.627
Psychomotor
agitation
72.5 72.4 74.0 1.5 0.221 73.2 71.6 1.0 0.321 73.4 70.3 5.0 0.025 73.2 71.6 1.6 0.201
Fatigue 93.4 92.9 95.2 10.8 0.001 93.2 94.0 0.9 0.344 94.0 91.8 7.5 0.006 93.5 93.1 0.5 0.489
Worthlessness 90.1 89.5 92.1 8.6 0.003 90.0 89.4 0.4 0.552 89.3 92.3 11.0 0.001 89.6 92.1 8.2 0.004
Reduced
concentration
97.5 97.4 98.2 3.8 0.051 97.7 97.6 0.0 0.995 97.7 97.6 0.0 0.950 97.7 98.1 0.3 0.558




78.4 78.9 78.8 0.0 0.855 78.4 80.0 0.7 0.394 79.8 76.1 8.2 0.004 80.0 76.8 7.4 0.006
Decreased self
esteem
84.2 83.9 85.3 1.6 0.208 84.8 82.8 2.8 0.093 83.5 86.5 7.6 0.006 83.5 85.5 3.4 0.063
Decreased self
confidence




93.0 92.9 93.6 0.6 0.425 93.0 93.3 0.1 0.756 92.6 94.0 2.6 0.105 93.3 92.4 1.2 0.280
Diurnal variation 62.0 60.6 65.9 13.1 0.000 61.8 61.6 0.0 0.842 62.2 61.7 0.1 0.773 63.4 60.1 5.4 0.020
Decreased libido 88.8 88.3 91.0 8.0 0.005 88.4 88.9 0.2 0.694 89.8 86.1 14.2 0.000 89.5 88.2 1.7 0.192
Loss of ability to
enjoy good
things
86.2 86.1 87.2 1.1 0.304 86.5 85.1 1.5 0.221 87.0 83.6 10.3 0.001 86.7 84.5 4.4 0.035
Irritability or
anger
74.7 73.4 77.1 7.9 0.005 75.2 71.9 5.5 0.019 73.9 76.5 3.7 0.054 72.6 79.0 25.7 0.000
Hopeless 80.6 79.5 83.4 10.3 0.001 80.0 81.6 1.3 0.263 78.9 85.1 26.2 0.000 78.6 84.2 23.2 0.000
Cry a lot 67.4 66.6 69.4 3.9 0.048 67.8 67.0 0.3 0.597 66.2 71.2 11.9 0.001 65.7 71.2 16.2 0.000
Helpless 89.2 88.2 92.2 18.0 0.000 89.1 89.4 0.0 0.841 88.5 91.6 11.0 0.001 87.8 92.6 28.3 0.000
Nervous, jittery,
anxious
89.2 87.7 93.4 36.3 0.000 89.5 88.3 1.4 0.245 88.8 90.6 3.5 0.062 88.6 90.5 4.3 0.039
Average symptom
endorsementa
72.9 72.4 74.6 -6.2 0.000 72.9 72.6 0.9 0.348 72.8 73.3 − 1.3 0.192 72.6 73.9 -3.8 0.000
AAO, age at onset; Adv., adversity; FH, family history; PRS, polygenic risk score; χ2, chi-squared; P, P-value. Endorsement rates are expressed in percentages.
In bold: P-values< 0.0005 (Bonferroni–corrected).
a Statistic for average symptom endorsement is t-test.
Fig. 1. Average symptom endorsement rates per subsample. AAO, age at onset; FH, family history; PRS, polygenic risk score. For abbreviation of symptoms see legend Fig. 2. Mean
endorsement rates for each subsample for all 24 symptoms during the worst depressive lifetime episode.
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significantly different and correlations of endorsement rates were very
high (Spearman’s r ranging from 0.95 to 0.99). If there were differences
in endorsement rates, absolute differences between the subsamples
were modest (maximum of 6.2%). The maximum statistical differences
in endorsement rates (in terms of χ2) concerned the symptoms 1)
feeling nervous, jittery, and anxious, more often observed in cases with
a positive instead of a negative family history of MD, 2) hypersomnia in
cases with an earlier instead of a later age at onset, and 3) appetite gain,
in adversity-exposed instead of adversity-unexposed cases (Table 2,
Additional Fig. 1).
On average, subjects with a family history of MD endorsed more
symptoms than subjects without a family history of MD (74.6% vs
72.4%, P<0.0005) and had significantly higher endorsement rates for
hypersomnia, diurnal variation, helplessness, and feeling nervous. Also,
adversity exposed subjects endorsed more symptoms than adversity
unexposed subjects (73.9% vs 72.6%, P<0.0005) with significantly
higher scores for appetite and weight gain, hypersomnia, suicidal
ideations, irritability, hopelessness, crying and helplessness (Table 1).
In contrast, average endorsement rates for subjects with an earlier
age of onset compared to those with a later age of onset were very
similar (73.3% vs. 72.8%, P = 0.19), but scores on specific individual
symptoms differed across these groups. Women who were younger at
onset reported significantly more appetite gain, hypersomnia, and
hopelessness, whereas women who were older at onset reported sig-
nificantly more appetite and weight loss, insomnia and decreased li-
bido. There were no significant differences in average endorsement
rates or on any of the 24 symptoms between cases with a high versus
low PRS.
3.3. Network structure in the entire sample
The network estimated using all cases (n = 5784) including all 24
symptoms displayed characteristics that were also found in the sub-
sequent network comparisons (Fig. 2, Additional Table 2 and
Additional Fig. 2). These network results are consistent with previous
findings in 3463 depressed outpatients (Fried et al., 2016a) and in a
previous study in MD-cases in CONVERGE, which aimed to investigate
the potential difference between DSM- and non-DSM depressive
symptoms (Kendler et al., n.d.). Note that the current study and this
previous study in CONVERGE used a largely overlapping sample and
network estimation methods, but with a different aim and using a
slightly different set of symptoms (the current study investigated 24
instead of 19 depressive symptoms, as it included all disaggregated
psychomotor symptoms and excluded interest loss). In all three studies,
the networks included a mix of both DSM and non-DSM symptoms. The
network findings did not support a clear separation between these two
classes of symptoms.
The strongest positive edges were observed between increased ap-
petite and weight gain (penalized OR 34.3), decreased appetite and
weight loss (OR 5.7), hopelessness and suicidal ideation (OR 5.2), low
self-esteem and low self-confidence (OR 4.18), hopelessness and help-
lessness (OR 3.6). As might be expected, the strongest negative edges
were observed between insomnia and hypersomnia (OR 0.2), appetite
gain and appetite loss (OR 0.3), weight gain and weight loss (OR 0.4).
The number of connecting edges per symptom varied. Psychomotor
retardation was connected to more than 50% of the symptoms (15 out
of 23), which was also true for psychomotor agitation, hopelessness (13
out of 23) and appetite loss (12 out of 23). The remaining symptoms
were connected with at least three other symptoms, except for the
symptom distinct quality of depressed mood, which was not connected
to any other symptoms.
The intercepts – i.e. the independent tendency for symptoms to be
non-zero as estimated by the average intercept for each symptom in the
logistic regression analyses used to estimate the networks – were
highest for distinct quality of depressed mood, insomnia, and fatigue
and lowest for weight gain, psychomotor retardation, and hopelessness
(Additional Table 2). Bootstrapping indicated good accuracy and sta-
bility with narrow confidence intervals for the edge weights and stable
centrality estimates (Additional Figs. 3–6).
3.4. Network comparisons
First, network comparison tests showed no significant differences in
network structure across subsamples with higher vs. lower genetic risk
and higher vs. lower environmental risk (Fig. 3). P-values for network
structure and global strength – representing the proportion of differ-
ences based on randomly drawn subsamples that were at least as ex-
treme as the observed test statistic – were larger than 0.12. In addition,
post-hoc analyses that were performed to assess the potential influence
of differences in subsample size did not result in significant differences
in network structure or global strength (Additional Table 3). With re-
gard to individual edges, we found no differences in edge strength for
the subsamples examined, with one exception. The edge between ap-
petite loss and psychomotor agitation was significantly stronger in
adversity unexposed cases (OR = 1.82) than in adversity exposed cases
(OR = 1.00).
Fig. 2. Estimated regularized symptom network
for the full sample (n = 5784). Green edges in-
dicate positive (partial) associations; red edges in-
dicate negative associations. Thicker/darker lines
indicate stronger associations. (For interpretation of
the references to color in this figure legend, the
reader is referred to the web version of this article.)
H.M. van Loo et al. Journal of Affective Disorders 227 (2018) 313–322
317
Fig. 3. Permutation testing results for network comparisons of network structure and global strength. From top to bottom: Each row represents the distribution of permutation
tests for 1. Family history; 2. Polygenic risk score high vs. low; 3. AAO<28 vs>= 28 years; 4. Adversity exposed vs. unexposed. p = The P-value equals the proportion of network
differences from the 1000 randomly regrouped subsamples at least as extreme as the network differences in the original subsamples. The triangle on the x-axis represents the estimated
difference in the original data.
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Second, to estimate the similarity of the networks, we correlated the
edge weights with each other for each of the four subsample compar-
isons. Spearman rank-order correlations ranged from 0.60 (family his-
tory negative vs. positive) to 0.71 (PRS low vs. high), indicating strong
similarities.
Third, on average, symptom intercepts were higher in women with
higher genetic or environmental risk, indicating a tendency for the
networks to be more activated. The difference in intercepts was most
pronounced for cases with a positive family history as compared to
cases with a negative family history (Additional Table 4).
3.5. Sensitivity analyses
Post-hoc sensitivity analyses were performed to assess the potential
influence of recall bias on the results. We compared 2797 cases with an
interval ≤ 1 year between the interview and the worst lifetime episode
of MD with 2956 cases with an interval> 1 year between interview and
the worst lifetime episode of MD. Symptom endorsement rates were
largely similar in these two subsamples. Out of 24 symptoms, two
symptoms were significantly more often endorsed in the subsample
with a longer recall period, viz. weight loss and cry a lot (P<0.0005).
Spearman rank-order correlations between mean endorsement rates in
the two subsamples were 0.99. Network comparison tests showed no
significant differences in global strength (P = 0.92), network structure
(P = 0.822) or individual edges (P> 0.28).
4. Discussion
To further our understanding of the heterogeneity of MD, we in-
vestigated symptom patterns and symptom networks across different
levels of genetic and environmental risk in a large sample of Han
Chinese women with recurrent MD. Apart from some moderate differ-
ences – for example, women with an earlier age at onset reported more
often appetite gain, hypersomnia and hopelessness than women with an
older age at onset – symptom endorsement rates were very similar for
women with higher versus lower genetic risk and adversity exposed
versus unexposed women. In addition, network comparison testing did
not identify statistically significant differences in network structure,
strength or associations between symptoms in these subgroups despite
the high power due to large samples. Overall our findings suggest that
types of symptoms and interconnectivity between symptoms for women
experiencing a full MD syndrome are robust across different degrees of
genetic and environmental risk.
4.1. Relation to previous studies
Although a range of studies have investigated differences in en-
dorsement rates of depressive symptoms in subgroups of population-
based samples with depressive symptoms (Fried et al., 2015b, 2014;
Hybels et al., 2012; Keller et al., 2007; Keller and Nesse, 2006, 2005),
no studies have investigated network structure in a clinical sample
across different levels of genetic or environmental risk for MD like we
did in this study.
The most comparable studies to date also investigated differences in
associations between depressive symptoms after life events (Cramer
et al., 2012; Fried et al., 2015a). Cramer et al. compared depressive
symptom networks in a sample from the general population experien-
cing at least two depressive symptoms after four distinct stressful life
events had occurred: stress, romantic loss, health problems, and inter-
personal conflicts. Average tetrachoric correlations between depressive
symptoms diverged across the subsamples who experienced one of the
four different stressful life events, with for instance ‘loss of interest’
being more highly connected to other depressive symptoms after ro-
mantic loss than after health problems (Cramer et al., 2012). Fried et al.
(2015a) compared depressive symptoms after partner loss in a pro-
spective study of married elderly couples. This study included ‘partner
loss’ as a node in the depressive symptom network. Partner loss mainly
affected loneliness, and loneliness in turn was associated with feeling
sad and less happy, which could be an indication of network differences
in widow(er)s versus controls.
The different findings in these two prior studies compared to our
study could indicate that symptom networks diverge after specific types
of stressful life events as opposed to after adversity in general.
However, given the substantial differences between our study and the
former studies in sample (population-based samples with depressive
symptoms versus clinical sample with recurrent fully syndromal MD)
and statistical methods (network estimation and comparison), follow-
up studies are needed to clarify which of these aspects explain the
different findings.
4.2. Study limitations
Our sample selection counts as one of the limitations of our study.
We used data from a sample of Han Chinese women treated for re-
current, severe depression; endorsement rates for 12 of the 24 symp-
toms were higher than 80%. It might be that this high degree of severity
affected the network structure, for example because of ceiling effects
(Terluin et al., 2016). In that case, samples with lower degrees of MD-
severity could have shown more differences in symptom networks,
possibly related to higher variance and unidimensionality (Fried et al.,
2016b). Furthermore, our sample included only female patients,
whereas gender differences in depressive symptoms have been found in
previous studies (Khan et al., 2002; Romans et al., 2007). Future studies
are needed to investigate whether similar conclusions hold in male
patients with MD.
Second, we used patients’ retrospective reports of symptoms during
their lifetime worst episode of MD, so we can only examine average
undirected relations between symptoms in networks. Longitudinal data,
on the other hand, would have given the opportunity to discover spe-
cific temporal or directed relationships between symptoms for specific
subsamples (e.g., guilt predicting suicidality in one subgroup, but sui-
cidality predicting guilt in another subgroup) or for specific individuals
(De Vos et al., 2017). In addition, more fine-grained assessments of
symptoms as opposed to dichotomous (present/absent) assessments of
symptoms could have improved power to pick up differences in net-
work structure.
Third, the three measures of genetic risk – family history of MD,
earlier age of onset, and PRS for MD – all capture a limited degree of
genetic risk for MD (Kendler et al., 2005; Peterson et al., 2016). Under
the one child policy in China, sibship sizes in the families were small,
possibly contributing to the limited power of this method. Early age of
onset and a family history of MD might partly be attributed to early
environmental factors, and the PRS for MD explains only 1.1% of
variability for MD risk in cases versus controls (Peterson et al., 2016).
This limitation has likely decreased power to detect differences across
different levels of genetic risk. In addition, the PRS used in this study
was designed to discriminate between MD-case and control status, as
opposed to discriminate between more and less severely ill MD-cases.
Future studies are needed to investigate whether different genetic risk
factors are involved in MD-onset versus subsequent MD-severity, and
eventually create PRS for MD-severity within cases.
Fourth, simulation studies testing the Network Comparison Test and
network estimation methods for binary data resulted in very low rates
of false-positive significant edges or network differences, but higher
false negative rates (Van Borkulo et al., 2017, 2014). Despite the large
sample size in this study, these methods could have failed to identify
very subtle differences between networks, although the clinical re-
levance of finding such minor differences is disputable. Nevertheless,
future studies should assess the replicability of our findings based on
these new statistical methods.
Fifth, estimated intercepts for symptoms in the networks were on
average higher in the subsamples with higher genetic risk or adversity,
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which possibly indicates a tendency for the networks to be more acti-
vated. We were not able to test whether these potential important
differences were statistically significant, as the required permutation
tests are currently not available. Extensions of network comparison
tests are warranted to investigate these potential differences between
the networks.
4.3. Implications of findings
Given the fact that this is the first study of its kind in terms of study
sample and methods, and other studies have found indications that
symptom patterns might differ across different types of life events (e.g.,
Cramer et al., 2012; Fried et al., 2015a, 2015b), we should be careful in
drawing conclusions. If, however, the current findings prove to be ro-
bust in replication studies, how might the similar types and associations
of symptoms in patients with MD across different levels of genetic and
environmental risk be interpreted?
The findings could be compatible with the concept of ‘equifinality’,
derived from general systems theory, which refers to the fact that the
same end state may be reached from a variety of different initial con-
ditions and through different processes (Cicchetti and Rogosch, 1996).
In other words, different risk factors upstream might result in a similar
symptom structure downstream. Genetic risk and environmental risk
for MD might thus be associated with different pathways upstream, but
eventuate in similar depressive symptom feedback loops and mutual
reinforcements downstream. In this sense, the syndrome of MD could be
compared to other medical conditions, such as that bacterial infections,
auto-immune processes and cancer all of which can lead to a similar
syndrome with symptoms of fever, malaise, and anorexia.
For clinical practice, the findings can be viewed both as reassuring
and disappointing. On the one hand, the robust structure of MD could
indicate that mechanisms on the symptom level (how symptoms are
connected) might not be highly diverse in patients with MD – e.g., in-
somnia is associated with fatigue in most patients – although we should
be cautious in translating group-level associations to individuals
(Molenaar, 2008). On the other hand, within this sample of female
patients with recurrent MD, this study did not identify potential specific
mechanisms on the symptom level for MD subtypes with different levels
of genetic or environmental risk, and therefore cannot provide much
insight for developing personalized treatments based on these distinc-
tions.
For research, these findings suggest that future studies should look
beyond depressive symptoms in search of pathways leading to MD. If
the syndrome of MD is very similar in patients with different proximal
risk factors, and we aim to trace the differential pathways from the
proximal risk factors to the full syndrome of MD, we should probably
expand our search to different types of information instead of studying
depressive symptoms only. Depressive symptoms might not convey
enough information to trace differential pathways leading to the syn-
drome of MD. Similarly, the identification of specific course of illness
patterns in patients with MD improved by including a broad range of
clinical predictors in addition to depressive symptoms (van Loo et al.,
2015; Wardenaar et al., 2014). Another approach would be to focus on
pathways to individual depressive symptoms instead of the full syn-
drome of MD (Fried et al., 2015b, 2014).
Future studies are warranted to study 1) whether specific instead of
aggregate genetic and environmental risk factors have a stronger im-
pact on symptom networks, 2) whether different degrees of disease
severity (e.g. in terms of number of symptoms, recurrences, types of
symptoms) impact on symptom networks, and 3) how different types of
risk factors upstream eventuate in a final common pathway and a ro-
bust structure of MD downstream. The aim of these studies would be to
improve our understanding in the processes leading to MD and identify
new possibilities to interfere.
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